查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1627605

骨化二醇的全球市场：预测（2025-2030）

Calcifediol Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 120 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球骨化二醇市场规模预计将以6.24%的复合年增长率成长，从2025年的19,4395万美元达到2030年的26​​3,161万美元。

骨化二醇，也称为 25-羟基维生素 D3，是维生素 D 的一种，是在阳光和食物中维生素 D3 羟基化过程中在肝臟中产生的。它在肾臟中进一步羟基化形成骨化三醇，即维生素 D3 的活性形式。

骨化二醇以胶囊或液体形式给药，可治疗维生素 D 缺乏症、难治性佝偻病、遗传性低磷血症和次发性甲状旁腺功能低下症。它也用于治疗慢性肾衰竭患者的低血钙症和肾性骨营养不良。它与钙结合使用可预防骨质疏鬆症。它也用于动物饲料中，透过提高牲畜和家禽的整体品质来提高维生素 D 水平和饲料转换率。

骨化二醇的功效是胆钙化醇的三倍，胆钙化醇通常用于治疗维生素 D 缺乏症。此外，全球维生素 D 缺乏症日益严重和人口老化正在推动骨化二醇补充剂的市场成长。此外，其在治疗次发性副甲状腺机能亢进、治疗低血钙和预防骨质疏鬆症的应用正在导致市场扩张。

骨化二醇市场驱动因素

  • 维生素 D 缺乏的增加、微量营养素补充剂健康意识的增强将推动骨化二醇市场的成长

全球维生素 D 缺乏症患者的数量正在增加。此外，全球老年人口正在增加。包括老年人在内的人们维生素 D 缺乏症的增加，产生了对维生素 D 补充剂的需求。骨化二醇是其他维生素 D 的更好替代品，透过骨化二醇补充剂提供有效的解决方案来满足您的维生素 D 需求。此外，年轻人的健康意识不断增强。因此，对微量营养素的需求增加，补充维生素D的骨化二醇补充剂的需求也显着增加。

美国国家生物技术资讯中心的一项研究表明，76.6%的参与者血清25-羟基维生素D缺乏症低于75 nmol/l，显示维生素D缺乏症的盛行率很高。在全球范围内，约 30-45% 的人（即约 10 亿人）缺乏维生素 D。

骨化二醇市场的地域展望

  • 预计在预测期内，北美将占据骨化二醇最大的市场占有率

从地区来看，全球市场分为亚太地区、北美、南美、欧洲和中东/非洲。在预测期内，北美可能占据骨化二醇的最大市场占有率。

与其他地区相比，北美地区的人们对营养补充品越来越感兴趣。由于先进的医疗基础设施的普及以及卫生部门的重大创新和进步，预计该地区骨化二醇市场将出现成长。此外，北美的老年人口正在增加。根据美国人口普查局计划，美国约有 7,700 万人年龄在 65 岁及以上。因此，在预测期内，北美将主导该市场。

为什么要购买这份报告？

  • 富有洞察力的分析：获得涵盖关键和新兴地区的深入市场洞察，重点关注客户细分、政府政策和社会经济因素、消费者偏好、行业和其他子区隔。
  • 竞争格局：了解世界主要企业采取的策略策略，并了解透过正确的策略渗透市场的潜力。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力做出策略决策，在动态环境中释放新的业务流和收益。
  • 受众广泛：对于新兴企业、研究机构、顾问、中小企业和大型企业有用且具有成本效益。

它有什么用？

产业和市场考量、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范与影响、新产品开发、竞争影响

调查范围

  • 2022年至2030年的实际资料和预测
  • 成长机会、挑战、供应链前景、法规结构、顾客行为、趋势分析
  • 竞争定位、策略和市场占有率分析
  • 区域收益成长和预测分析，包括细分市场和国家
  • 公司简介（主要是策略、产品、财务资讯、主要动态等）

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现
  • 分析师观点

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析

第五章骨化二醇市场：依应用分类

  • 介绍
  • 药品
  • 动物饲料
  • 其他的

第六章骨化二醇市场：依地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 其他的
  • 中东/非洲
    • 沙乌地阿拉伯
    • 以色列
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第七章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 併购/协议/合作
  • 竞争对手仪表板

第八章 公司简介

  • Chemvon Biotechnolgy Co.
  • Haoyuan Chemexpress Co. Ltd.
  • BOC Science
  • Pharmaffiliates
  • DSM-Firmenich
  • Carbogen AMCIS
  • Chemicea
  • Midas Pharma
  • ApexBio Technolgy
  • OPKO Pharmaceuticals LLC
  • Nouveau Healthcare
  • Tocris Bioscience
简介目录
Product Code: KSI061614181

The Calcifediol Market is expected to grow at a CAGR of 6.24%, reaching a market size of US$2,631.61 million in 2030 from US$1,943.95 million in 2025.

Calcifediol is a form of Vitamin D, also known as 25-hydroxyvitamin D3, produced by the liver by the process of hydroxylation of Vitamin D3 that we get from sunlight or diet. It is further hydroxylated in the kidney to form Calcitriol, an active form of vitamin D3.

Calcifediol in capsule or liquid dosage treats vitamin D deficiency or insufficiency, refractory rickets, familial hypophosphatemia, and secondary hypoparathyroidism. It is used to treat hypocalcemia and renal osteodystrophy in patients suffering from chronic renal failure. It is used with calcium to prevent osteoporosis. It is also used in animal feed to improve its vitamin D level and feed conversation ratio by improving the overall quality of livestock and poultry.

The rising demand for calcifediol is attributed to its more advantageous features than the other forms of vitamin D. Calcifediol is 3 times more potent than cholecalciferol, commonly used to treat vitamin D deficiency. At the same time, its absorption rate is higher than that of other forms of vitamin D. Furthermore, the increasing Vitamin D deficiency worldwide, along with the aging population, is driving the market growth for calcifediol in the form of supplements. Moreover, its use in treating secondary hyperparathyroidism, managing hypocalcemia, and preventing osteoporosis is leading to market expansion.

Calcifediol Market Drivers

  • Rising Vitamin D deficiency, along with rising health awareness about micronutrient supplementation, will drive the calcifediol market growth

Globally, there is an increase in number of people with Vitamin D deficiency. The number of geriatric populations is also rising worldwide. The rising Vitamin D deficiency among the people, including the aged population, is creating demand for Vitamin D supplements. Calcifediol, a better alternative than other vitamin D, provides an effective solution to meet the demand for vitamin D in calcifediol supplements. Additionally, there is increasing health awareness among youth for their health and wellness. This has led to increased demand for micronutrients, resulting in a significant rise in the need for calcifediol supplements for vitamin D supplementation.

As per a study by the National Center of Biotechnology Information, 76.6% of participants had serum 25-hydroxyvitamin D deficiency below 75 nmol/l, showing a higher prevalence of deficiency of vitamin D. Globally, approx. 30-45% of people have vitamin D deficiency, making it around 1 billion.

Calcifediol Market geographical outlook

  • North America would be the largest market shareholder for calcifediol in the forecast period.

Region-wise, the global market is segmented into Asia-Pacific, North America, South America, Europe, Middle East and Africa. In the forecast period, North America would hold the largest market share for Calcifediol.

There are increasing trends among people in North America, compared to other regions, for dietary supplements. With the prevalence of advanced healthcare infrastructure and significant innovations and advancement in the health sector, this region is poised for growth in the Calcifediol market. Additionally, North America is experiencing a demographic shift towards the older population. In the United States of America, there would be around 77 million people aged above 65 as per U.S. Census Bureau Project. Hence, North America will dominate this market in the forecast period.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Calcifediol market is analyzed into the following segments:

By Application

  • Pharmaceuticals
  • Animal Feed
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits for the Stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Supplier
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. CALCIFEDIOL MARKET BY APPLICATION

  • 5.1. Introduction
  • 5.2. Pharmaceuticals
  • 5.3. Animal Feed
  • 5.4. Others

6. CALCIFEDIOL MARKET BY GEOGRAPHY

  • 6.1. Introduction
  • 6.2. North America
    • 6.2.1. United States
    • 6.2.2. Canada
    • 6.2.3. Mexico
  • 6.3. South America
    • 6.3.1. Brazil
    • 6.3.2. Argentina
    • 6.3.3. Others
  • 6.4. Europe
    • 6.4.1. UK
    • 6.4.2. Germany
    • 6.4.3. France
    • 6.4.4. Italy
    • 6.4.5. Others
  • 6.5. Middle East and Africa
    • 6.5.1. Saudi Arabia
    • 6.5.2. Israel
    • 6.5.3. Others
  • 6.6. Asia Pacific
    • 6.6.1. Japan
    • 6.6.2. China
    • 6.6.3. India
    • 6.6.4. South Korea
    • 6.6.5. Indonesia
    • 6.6.6. Thailand
    • 6.6.7. Others

7. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 7.1. Major Players and Strategy Analysis
  • 7.2. Market Share Analysis
  • 7.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 7.4. Competitive Dashboard

8. COMPANY PROFILES

  • 8.1. Chemvon Biotechnolgy Co.
  • 8.2. Haoyuan Chemexpress Co. Ltd.
  • 8.3. BOC Science
  • 8.4. Pharmaffiliates
  • 8.5. DSM-Firmenich
  • 8.6. Carbogen AMCIS
  • 8.7. Chemicea
  • 8.8. Midas Pharma
  • 8.9. ApexBio Technolgy
  • 8.10. OPKO Pharmaceuticals LLC
  • 8.11. Nouveau Healthcare
  • 8.12. Tocris Bioscience